Simultaneous immunological titration of DOPA and 5-hydroxytryptophan decarboxylase activities, from a number of tissues of various species, showed that the two activities were not distinguishable with a monospecific antiserum to hog kidney decarboxylase. Together with previous findings, these data firmly establish thb concept that in mammalian tissues the two enzyme activities are associated with a single protein, namely aromatic L-amino acid decarboxylase.
The enzymatic synthesis of the biogenic amines serotonin, dopamine, and norepinephrine involves decarboxylation of the corresponding amino acids, 5-hydroxytryptophan and 3.4-dihydroxyphenylalanine (DOPA). DOPA decarboxylase (EC 4.1.1.26) was the first enzyme of the catecholamine biosynthetic pathway to be discovered (1) . After the isolation and identification of serotonin (2, 3), Clark, Weissbach, and Udenfriend (4) found significant DOPA decarboxylase activity in their most highly purified preparations of 5-hydroxytryptophan decarboxylase (EC 4.1.1.28) from guinea pig kidney. For a number of reasons, they considered that the two activities represented distinct enzymes. However, as analytical procedures improved; reports from many laboratories made it appear more likely that a single enzyme acts on both substrates (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . In view of their evidence that a partially purified enzyme from guinea pig kidney decarboxylated a large number of aromatic -amino acids, including DOPA and 5-hydroxytryptophan, Lovenberg , Weissbach, and Udenfriend (i4) proposed that the enzyme be named "aromatic i-amino acid decarboxylase".
Because the amiies resulting from decarboxylation are localized differently and are thought to have distinct physiological functions, many investigators have found it difficult to accept the hypothesis that the same enzyme is involved in both pathways. The recent demonstration that a single, homogeneous enzyme from hog kidney decarboxylates all the naturally occurring aromatic amino acids (17) is a necessary, but not a sufficient, condition for the "single enzyme" hypothesis. The possibility remains that a second enzyme may also exist, at least in some tissues. Recently, Sims and Bloom (18) have reported that, after intracisternal administration of 6-hydroxydopamine to rats, DOPA decarboxylase activities were substantially decreased in certain areas of the brain, while the 5-hydroxytryptophan decarboxylase activities were no different from controls.
In the present report, evidence is presented in support of the "single enzyme" hypothesis. It is shown that DOPA decarboxylase and 5-hydroxytryptophan decarboxylase activities are not immunologically distinguishable. DOPA decarboxylase activity was assayed as described (17) . The availability of carboxyl-labeled 5-hydroxytryptophan made it possible to assay 5-hydroxytryptophan decarboxylase by a basically similar method. All conditions were the same as those for the DOPA decarboxylase assay, with the following exceptions: the buffer was Tris * HCl (pH 8. Whole brains or pineals were homogenized as described in Methods. Aliquots (60 ml, hog; 5 ml, rat; 1 ml, rabbit pineal) of the crude homogenates were centrifuged at 27,000 X g for 15 min. The precipitates were washed twice with the same buffer [5 mM sodium phosphate buffer (pH 7.2), 80 ml, 5 ml, and 1 ml, respectively]. The washed precipitates were then resuspended in the same buffer (45 ml, 3.75 ml, and 1 ml, respectively). Each fraction was assayed for both enzyme activities. Recoveries are based on the activity of the crude homogenate.
that the enzyme was preincubated in the presence of 0.1 mM 3-hydroxy-4-bromobenzyloxyamine, a potent decarboxylase inhibitor (also known as Brocresine or NSD-1055). Pyridoxal phosphate and substrate were then added before the incubation period. The production of labeled CO2 was linear with time and with enzyme concentration for at least 30 min and for the first 100 nmol of C02. One unit of enzyme activity is defined as that amount of enzyme that produces 1 nmol of CO2 per min under the specified conditions with DOPA as substrate.
The preparation of goat antiserum to porcine aromatic Lamino acid decarboxylase has been described (17, 19) . The antiserum was shown to be monospecific by double-diffusion assay and by immunoelectrophoresis, and was shown to cross- Crude supernatants were prepared as for the experiment presented in Fig. 1 and assayed The experimental conditions were similar to those of the experiment in Fig. 1 Knowing the approximate endpoints for the DOPA decarboxylase activity of the various species, it was possible to perform more precise titrations -and assay for both enzyme activities. Amounts of antiserum were chosen such that several points would be-in antigen excess and one point in antibody excess for complete removal of enzyme activity. The "single enzyme" hypothesis would predict that the loss of a given fraction of one activity should be associated with the loss of the same fraction of the other activity. When one activity is completely lost, the other should be lost as well. The results shown in Table 3 are just those predicted by the hypothesis. When the same amounts of control serum were substituted for antienzyme serum, the recoveries of the enzyme activities were 98 ± 9% and 97 9% (SD) for DOPA and 5-hydroxytryptophan decarboxylase, respectively.
Essentially the same data are presented in Fig. 2 , -in which the percentage of 5-hydroxytryptophan decarboxylase activity recovered in the supernatant has been plotted as a function of the percentage of DOPA decarboxylase activity remaining. If both, activities were associated with a single antigenic entity (that is, with aromatic iamino acid decarboxylase), the plot should be a straight line with a slope of 1 Table 3 are presented graphically, with 5-hydroxytryptophan decarboxylase activity remaining in the 100,000 X g supernatant after treatment with antiserum plotted as a function of the DOPA decarboxylase activity remnaining. Each point represents a single assay for each substrate.
ordinate intercept of 1.4%o with a correlation coefficient of 0.989.
DISCUSSION
The present studies corroborate and extend previous findings that a single enzyme is responsible for the decarboxylation of both DOPA and 5-hydroxytryptophan. If there were more than this one decarboxylase capable of acting on either of these substrates, it should have been possible to neutralize one enzyme without inactivating the other. Conversely, if only one enzyme acts on both substrates, the activities should be in constant proportion. The results reported here show that a specific antiserum directed against aromatic iamino acid decarboxylase neutralized both DOPA and 5-hydroxytryptophan decarboxylase activities proportionately. Under conditions of antibody excess, just sufficient tp completely neutralize DOPPA decarboxylase activity, &-hydroxytryptophan decarboxylase activity was also completely inactivated. These results are just those predicted by the "single enzyme" hypothesis.
Since only soluble activities could be estimated by the immunological tritration procedure used here, it was necessary to consider the possibility that one activity is preferentially contained in (or adsorbed to) particulate cellular material. However, both activities have been found to be soluble in peripheral tissues (4, 20, 21) . Nevertheless, under certain homogenization conditions, large amounts of each activity from the brain sediment with particulate fractions (22, 23) . The particle-bound activities may be released by osmotic shock or by sonication. Therefore, in the present studies tissues were homogenized in dilute buffer, and the soluble and particulate fractions of brain homogenates were assayed to insure that the enzyme activities of the crude supernatant were representative of the overall cellular content of both activities. This was found to be the case: most of the activity for each substrate was found in the crude supernatant and virtually all of each enzyme activity was obtained in the supernatant fractions by simply washing the sediment with buffer.
While it is possible that there are distinct decarboxylases for the two amino acids in tissues or species other than those examined, this seems unlikely since a single enzyme was found in central and peripheral tissues of all three species. If one were to speculate on a tissue likely to contain a specific 5-hydroxytryptophan decarboxylase, one might well choose the pineal gland, in which the synthesis of serotonin and its derivative, melatonin, is a major metabolic pathway. The levels of norepinephrine, serotonin, and melatonin in the pineal and in the nerve endings impinging upon it undergo rhythmic diurnal fluctuations (24) (25) (26) . Since these fluctuations are large (from 2-to 12-fold) and are out of phase, one might expect the enzymes involved in the synthesis of these compounds to be under strict and independent control, yet only a single decarboxylase was found in the rabbit pineal.
It is conceivable that a second enzyme does exist, but its level is too low to be detected by our assay. However, the sensitivity of the assay is sufficient to detect as little as 1% of the original activity if it did not react with antiserum (except in the case of the hog cerebellum, where 2% could have been detected). It is unlikely that such a low activity would be physiologically significant.
Finally, it could be argued that a second enzyme exists but that it crossreacts strongly with the antiserum. This possibility cannot be completely excluded by our results. However, the results do impose the constraint that the second enzyme, if it exists, must be so closely related structurally to aromatic iamino acid decarboxylase as to be identical by the immunological criteria used in these studies. This structural homology, together with the kinetic findings suggesting that DOPA and 5-hydroxytryptophan compete for a single active site, provides convincing evidence that these two amino acids are decarboxylated by a single enzyme.
One of the predictions of the "single enzyme" hypothesis is that DOPA should be decarboxylated in cells that make serotonin. The dopamine thus produced might then displace the serotonin from storage. In fact, this has already been shown (27) (28) (29) . A corollary of this prediction is that 5-hydroxytryptophan should be decarboxylated in cells that make catecholamines.
The existence of a single enzyme catalyzing the same type of reaction in different biosynthetic pathways is an unusual circumstance in mammalian biochemistry. Examples that have been well established would include transketolase and transaldolase and the purine phosphoribosyltransferase, which catalyzes the formation of both inosinate and guanylate from the corresponding bases and 5-phosphoribosyl-l-pyrophosphate (see 30 , and refs. therein). The finding of the same genetically determined enzyme in the noradrenergic and serotonergic pathways indicates that the two pathways must be more closely related with respect to their evolution and function than has been supposed.
